GapRx 340B Consultants LLC works with covered entities to support 340B reporting, pharmacy oversight, analytics review, and operational coordination.
Managing a 340B program often involves coordinating information across multiple pharmacies, reporting systems, vendors, and internal workflows. As operational requirements continue to evolve, many covered entities are placing greater emphasis on structured reporting processes, data organization, and ongoing operational visibility.
GapRx 340B Consultants LLC provides consulting support related to analytics, dashboard reporting, claims review coordination, pharmacy oversight, manufacturer submission workflows, and operational reporting processes connected to 340B program management.
Founded in 2019 by Dr. Purnank Gandhi, PharmD, the company works with covered entities seeking additional support in organizing reporting structures, reviewing operational activity, and improving visibility into various areas of program administration.
For many organizations, program-related information exists across several disconnected systems, including pharmacy software platforms, internal reports, vendor tools, wholesaler data, and electronic health record systems. When information is dispersed across multiple sources, it can become more difficult to maintain consistent operational review processes and reporting visibility.
GapRx supports covered entities by helping organize operational information into more centralized reporting structures intended to support internal review and coordination efforts.
Evolving Operational Requirements
The 340B environment continues to involve changing administrative processes related to pharmacy operations, manufacturer reporting expectations, and operational workflows.
Covered entities may oversee both in-house and contract pharmacy arrangements, each involving separate reporting activity, claims information, dispensing data, and vendor coordination processes. In some situations, manufacturers may also request claims-level information through designated reporting platforms.
As these processes continue to evolve, many organizations have increased their focus on maintaining organized documentation practices, structured review procedures, and consistent reporting coordination.
Rather than relying entirely on periodic reviews, some covered entities are incorporating more routine operational monitoring and reporting analysis into their internal oversight processes.
Improving Visibility Through Analytics
One operational challenge for many organizations is coordinating large amounts of information across multiple reporting sources.
GapRx works with covered entities through analytics and dashboard-style reporting processes intended to support visibility into operational activity, reporting trends, pharmacy utilization information, and internal review procedures.
Reporting structures may include review areas such as:
- Prescription capture activity
- Claims reporting trends
- Contract pharmacy reporting activity
- In-house pharmacy utilization
- Operational reporting discrepancies
- Manufacturer submission tracking
- Pharmacy reporting metrics
- Documentation review coordination
- Workflow monitoring processes
Organized reporting structures can help internal teams review information more consistently across operational areas. These reporting processes may also support coordination between pharmacy teams, finance departments, compliance stakeholders, vendors, and operational leadership.
The company also works with organizations seeking to improve coordination between reporting systems, pharmacies, vendors, and operational review workflows.
Supporting Claims Review Processes
Claims-related reporting remains an ongoing operational consideration within many 340B programs. Traditional review methods may include periodic analysis, sampling procedures, or retrospective reporting reviews.
GapRx supports covered entities through structured claims review coordination processes intended to assist organizations with reviewing operational reporting activity, evaluating documentation consistency, and organizing claims-related information for internal oversight purposes.
This approach focuses on supporting operational visibility and organized review procedures rather than isolated reporting reviews alone.
The company also assists organizations with workflow coordination connected to manufacturer submission processes where applicable. Support may include data organization, reporting coordination, submission monitoring, and documentation review processes associated with operational reporting requirements.
Manufacturer Compliance, 340B ESP, and Rebate Model Readiness
Manufacturer-related reporting processes continue to represent an administrative consideration for many covered entities managing 340B operations.
GapRx supports organizations by assisting with reporting coordination efforts related to claims information, submission workflows, operational documentation, and reporting organization processes connected to manufacturer-supported platforms.
This may include support related to 340B ESP workflows and associated reporting coordination where applicable.
The company also works with organizations reviewing operational readiness processes connected to evolving reporting environments and administrative workflow expectations.
These support efforts may involve reporting organization, documentation review coordination, workflow monitoring, and operational reporting visibility across multiple pharmacy arrangements.
In-House and Contract Pharmacy Oversight
Covered entities often manage both in-house pharmacy operations and contract pharmacy relationships within their broader 340B programs. Each arrangement may involve different operational workflows, reporting structures, claims activity, and coordination procedures.
GapRx supports organizations by assisting with pharmacy reporting review processes, operational coordination efforts, and visibility into reporting trends across different pharmacy environments.
For in-house pharmacy operations, this may include support related to utilization reporting, prescription activity review, operational reporting visibility, and workflow coordination.
For contract pharmacy arrangements, support may include reporting coordination, operational monitoring processes, manufacturer-related workflow organization, and vendor reporting review procedures.
The company’s approach focuses on supporting organized oversight processes and improving operational visibility across multiple reporting areas.
What GapRx Helps Covered Entities Do
GapRx works with covered entities seeking support in areas including:
- Reporting visibility and analytics coordination
- Pharmacy activity review processes
- Claims reporting organization
- Manufacturer workflow coordination
- In-house and contract pharmacy reporting oversight
- Operational reporting visibility
- Documentation review coordination
- Ongoing operational monitoring processes
By combining analytics review, operational coordination, reporting organization, and pharmacy oversight support, the company assists covered entities seeking more structured approaches to 340B operational management.
A Data-Focused Approach to 340B Oversight
Although 340B administration involves detailed reporting activity and operational coordination, many organizations continue to focus on maintaining organized internal processes as administrative expectations evolve.
Dr. Gandhi’s background in pharmacy operations informs the company’s reporting-focused consulting approach. GapRx works with covered entities through operational review support, analytics coordination, reporting organization, and workflow visibility processes connected to broader 340B program administration.
Organizations interested in improving their 340B program can visit GapRx 340B Consultants or schedule a 340B strategy call through the website.
For additional insights, covered entities can also visit the GapRx Resource Center, which includes helpful articles on 340B compliance, ESP submissions, in-house pharmacy strategy, analytics, dashboards, manufacturer requirements, rebate model updates, and program optimization.
Readers are encouraged to subscribe for updates as new resources, industry insights, and 340B program guidance are added regularly.
Professional updates and insights are available via GapRx LinkedIn Page and Dr. Purnank Gandhi’s professional profile.
